QPPV.COM KNOWLEDGE ASSESSMENT

Fluticasone Furoate: Discovery, Development, Safety and Pharmacovigilance

Test your understanding of the concepts covered by Fluticasone Furoate: Discovery, Development, Safety and Pharmacovigilance.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A reviewer is interpreting the 52-week paediatric nasal study that found a mean growth-velocity difference of -0.27 cm/year for fluticasone furoate versus placebo. Which conclusion is best supported?
Question 2 of 10 Which evidence-handling practice is most appropriate when reviewing safety reports for nasal fluticasone furoate, inhaled monotherapy, and fixed-combination inhalers?
Question 3 of 10 A spontaneous report says only that the patient used “fluticasone” before developing an adverse event. What is the best product-identification action?
Question 4 of 10 A medication history identifies a patient’s previous treatment as fluticasone propionate and current treatment as fluticasone furoate. Which interpretation is most appropriate?
Question 5 of 10 A study finds no statistically significant difference in one lung-function endpoint when vilanterol is added to fluticasone furoate, while another study reports fewer severe exacerbations with the combination. How should these findings be interpreted?
Question 6 of 10 The US nasal OTC label advises stopping use and seeking medical advice for severe or frequent nosebleeds, while the EU Avamys SmPC lists epistaxis as very common. What is the best interpretation?
Question 7 of 10 In the SUMMIT COPD trial, which conclusion best reflects the primary outcome?
Question 8 of 10 A patient using nasal fluticasone furoate develops Cushingoid features while also taking a potent CYP3A inhibitor and inhaled corticosteroid therapy. Which assessment principle is most relevant?
Question 9 of 10 A patient using an inhaled fluticasone furoate product reports recurrent oral candidiasis. Which follow-up approach is most informative?
Question 10 of 10 A safety reviewer is comparing paediatric age limits for US Flonase Sensimist and EU Avamys. Which interpretation is most defensible?

Select an answer to continue.

QPPV.com